This report presents a real treatment case of a 55-year-old woman (code-named Elena). This case aims to objectively record the improvement process of chloasma and overall dullness caused by the use of AOMA W-PDRN SKIN WHITENING Injection Mesotherapy.
Case Summaries And Treatment Records
The core of this case is to provide a verifiable record of therapeutic efficacy. The treatment plan combines Mesotherapy injection technology with compound active ingredients including the main components of AOMA W-PDRN, glutathione and vitamin C.
●Patient: Elena, female, 55 years old.
●The main skin problems: There is stubborn pigmentation (chloasma) in the cheekbone area of the face, the overall skin luster is insufficient, and the skin tone is uneven.
●Core product: AOMA W-PDRN Skin Brightening Injection
●Treatment plan: AOMA W-PDRN Skin Brightening Injection Mesotherapy. The active ingredients are directly introduced into the mesoderm of the skin through microinjection.
●Treatment cycle: A total of 4 treatments were received, with a treatment interval of 15 days.
Treatment Process And Phased Therapeutic Effect Observation
Baseline Assessment Before Treatment
The pre-treatment imaging records showed that Elena had well-defined dark brown patches on both sides of her cheeks. The skin as a whole appears dull and lacks a healthy luster, and the texture of the skin is slightly dry.
On The 15th Day After The First Treatment
The immediate changes in the skin are mainly reflected in its texture. Elena reported that the dryness of her skin had significantly lessened and felt smoother to the touch. This indicates that the moisturizing ingredients in the formula have begun to take effect. There are very slight signs of fading at the edges of some pigmentation spots, but the main change lies in the initial improvement of skin hydration.
On The 30th Day After The Second Treatment
After two treatments, improvement entered a visible stage. Compared with the baseline photo, the overall pigment concentration in the pigmented area shows a visible decrease to the naked eye. At the same time, the skin tone in the central area of the face (the forehead and the chin) begins to become even and bright. At this point, the cumulative effects of multiple courses of plastic therapy began to show initially.
On The 60th Day After The Third Treatment
When the treatment was halfway through, the area of the main pigmentation spots significantly shrank, and the color changed from dark brown to light brown. The fineness and overall brightness of the skin have been further enhanced. This change is sufficient to draw the attention of those around.
After The Fourth Treatment And Follow-Up (Day 90)
After completing all four treatments and following up for one month, the therapeutic effect was consolidated. The large areas of pigmentation have faded to a degree that is hard to detect at social distance, leaving only extremely faint marks. The skin presents a uniform, bright and healthy state with a plump texture. This result confirms that long-term and stable improvement of skin tone can be achieved.
Patient's Self-Report:
My initial goal was to fade the pigmentation. However, the changes brought about by the entire course of treatment are comprehensive. The pigmentation has indeed significantly lightened. More importantly, the "texture" of the entire skin has completely changed - it has become brighter, fuller and healthier. This is a satisfactory overall improvement."
Scientific Elaboration Of The Therapeutic Effect Principle
The scientific basis for the therapeutic effect observed in this case lies in the synergistic effect of aesthetic therapy and specific active ingredients.
Mesotherapy, as a delivery technology, can break through the stratum corneum barrier of the skin and directly and precisely deliver macromolecular active substances such as AOMA W-PDRN to the skin layers that need to act, significantly improving bioavailability.
AOMA W-PDRN, As The Core, Has a Multi-Target Mechanism Of Action:
●Inhibiting melanin synthesis: The specific ingredients in the formula can intervene in the key links of melanin generation such as tyrosinase activity, reducing excessive pigment production from the source.
●Promoting skin repair and regeneration: W-PDRN has been proven to activate skin fibroblasts and promote the synthesis of extracellular matrices such as collagen, thereby improving skin texture and elasticity.
●Anti-inflammatory and barrier repair: The treatment simultaneously strengthens the skin barrier function and helps prevent the recurrence of pigmentation by reducing the micro-inflammatory state in the skin's lower layers.
This plan achieves an improvement in skin tone and texture from the inside out by periodically and systematically optimizing the internal environment of the skin.
Practical Implications For Professional Institutions
Based on the successful experience of this case, the following practical key points are provided for institutions that wish to carry out similar projects:
●Core Ingredient Selection: The stability of the therapeutic effect depends on the verified high-quality core ingredients, such as AOMA W-PDRN. The main components are PDRN, Tranexamic Acid, Glutathione 600, Glycolic Acid, Kojic Acid, Vitamin C, and Citric Acid. This is the foundation for building an effective treatment plan.
●Personalized Design Of Treatment Plans: Pigment management and skin regeneration is a gradual process. It is essential to clearly convey to the client the concept that multiple treatments are required and to formulate a complete treatment plan. This is the key to achieving lasting therapeutic effects and client satisfaction.
●Expectation Management And File Establishment: High-definition photos should be taken under the same conditions before and after treatment. It is recommended to use a professional skin analyzer to obtain objective data. These records can be used both to track progress and to demonstrate the treatment effect to potential clients.
●Customer Education: It is necessary to clearly explain to the customer the treatment principle, expected effect and necessary care measures, especially the importance of sun protection. Realistic goal setting helps to enhance customer satisfaction and treatment compliance.
●Combined Treatment Strategy: Mesotherapy can be used in combination with laser treatment, radiofrequency and other technologies to target different skin problems. Research shows that joint solutions often achieve an effect of "1+1>2".
Conclusion
The before-and-after comparison of Elena's treatment clearly confirmed the effectiveness of AOMA W-PDRN combined with Mesotherapy in improving pigmentation and enhancing skin quality. Through four standardized treatments, the client achieved significant pigment reduction and an overall improvement in skin quality.
The success of treatment depends on multiple elements: Effective active formulas, appropriate Mesotherapy techniques, personalized treatment plans, and the cooperation of the client. Only when these elements work together can the ideal therapeutic effect be achieved.
In the future, with the continuous development of Mesotherapy and its formulation, pigment management will become more precise and efficient. Continuous research will further refine the treatment plan and provide more optimized solutions for different types of pigment problems. This case provides practical references for this development direction.
Clinical description: This case record is based on the real treatment process. The actual effect may vary due to individual differences. Professional assessment should be conducted before treatment, and the operation should be carried out by trained professionals. All Messo treatments should comply with local medical norms and standard operating procedures.
